Helius Medical Technologies (HSDT) Projected to Post Quarterly Earnings on Wednesday

Helius Medical Technologies (NASDAQ:HSDT) is expected to be releasing its earnings data before the market opens on Wednesday, March 26th. Analysts expect Helius Medical Technologies to post earnings of ($0.94) per share and revenue of $0.10 million for the quarter.

Helius Medical Technologies Stock Performance

Shares of HSDT stock opened at $0.43 on Monday. The company has a market capitalization of $1.60 million, a P/E ratio of -0.07 and a beta of 1.62. Helius Medical Technologies has a fifty-two week low of $0.37 and a fifty-two week high of $7.19. The stock has a 50 day moving average price of $0.57 and a two-hundred day moving average price of $0.60.

About Helius Medical Technologies

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.